Dr. Farah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
Pittsburgh, PA 15232Phone+1 412-864-6600Fax+1 412-864-6669
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2010
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2002 - 2005
St Joseph's University Medical SchoolClass of 1997
Certifications & Licensure
PA State Medical License 2012 - 2024
WA State Medical License 2005 - 2014- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant Start of enrollment: 2012 Dec 01
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source Start of enrollment: 2015 Feb 11
Publications & Presentations
PubMed
- 12 citationsIV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant.Matthew J. Lim, Stebbings A, Sara J. Lim, Foor K, Jing-Zhou Hou
Bone Marrow Transplantation. 2015-06-08 - 10 citationsIntensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemia.Kelly Ross, Amanda L. Gillespie-Twardy, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou
Oncology Research. 2015-01-01 - 117 citationsPhase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.Michael Boyiadzis, Mounzer Agha, Robert L. Redner, Alison R. Sehgal, Annie Im
Cytotherapy. 2017-10-01
Abstracts/Posters
- Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvemen...Rafic Farah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Anal...Rafic Farah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
OncLive® Presents State of the Science Summit™June 3rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
